{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:20:57Z","timestamp":1778170857070,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100009330","name":"Medical Science and Technology Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"DOI":"10.1007\/s00432-026-06451-7","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T12:25:24Z","timestamp":1773491124000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigating the oncogenic potential of MTHFD2 in oral squamous cell carcinoma"],"prefix":"10.1007","volume":"152","author":[{"given":"Jiusong","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,14]]},"reference":[{"key":"6451_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"key":"6451_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/0022034519894963","volume":"99","author":"M Du","year":"2020","unstructured":"Du M, Nair R, Jamieson L, Liu Z, Bi P (2020) Incidence Trends of Lip, Oral Cavity, and Pharyngeal Cancers: Global Burden of Disease 1990\u20132017. J Dent Res 99:143\u2013151. https:\/\/doi.org\/10.1177\/0022034519894963","journal-title":"J Dent Res"},{"key":"6451_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2016.08.009","volume":"25","author":"GS Ducker","year":"2017","unstructured":"Ducker GS, Rabinowitz JD (2017) One-Carbon Metabolism in Health and Disease. Cell Metab 25:27\u201342. https:\/\/doi.org\/10.1016\/j.cmet.2016.08.009","journal-title":"Cell Metab"},{"key":"6451_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.Cd-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D (2022) Hallmarks of Cancer: New Dimensions. Cancer Discov 12:31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.Cd-21-1059","journal-title":"Cancer Discov"},{"key":"6451_CR5","doi-asserted-by":"publisher","first-page":"e920259","DOI":"10.12659\/MSM.920259","volume":"26","author":"H He","year":"2020","unstructured":"He H, Li PC, Jia W, Hu B, Ji CS (2020) High Expression of Methylenetetrahydrofolate Dehydrogenase 2 (MTHFD2) in Esophageal Squamous Cell Carcinoma and its Clinical Prognostic Significance. Med Sci Monit 26:e920259. https:\/\/doi.org\/10.12659\/MSM.920259","journal-title":"Med Sci Monit"},{"key":"6451_CR6","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1038\/s41467-018-04602-0","volume":"9","author":"J Hitzel","year":"2018","unstructured":"Hitzel J, Lee E, Zhang Y, Bibli SI, Li X, Zukunft S, Pfl\u00fcger B, Hu J, Sch\u00fcrmann C, Vasconez AE, Oo JA, Kratzer A, Kumar S, Rezende F, Josipovic I, Thomas D, Giral H, Schreiber Y, Geisslinger G, Fork C, Yang X, Sigala F, Romanoski CE, Kroll J, Jo H, Landmesser U, Lusis AJ, Namgaladze D, Fleming I, Leisegang MS, Zhu J, Brandes RP (2018) Oxidized phospholipids regulate amino acid metabolism through MTHFD2 to facilitate nucleotide release in endothelial cells. Nat Commun 9:2292. https:\/\/doi.org\/10.1038\/s41467-018-04602-0","journal-title":"Nat Commun"},{"key":"6451_CR7","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3892\/etm.2021.10135","volume":"22","author":"J Huang","year":"2021","unstructured":"Huang J, Qin Y, Lin C, Huang X, Zhang F (2021) MTHFD2 facilitates breast cancer cell proliferation via the AKT signaling pathway. Exp Ther Med 22:703. https:\/\/doi.org\/10.3892\/etm.2021.10135","journal-title":"Exp Ther Med"},{"key":"6451_CR8","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/jnci\/djy160","volume":"111","author":"HQ Ju","year":"2019","unstructured":"Ju HQ, Lu YX, Chen DL, Zuo ZX, Liu ZX, Wu QN, Mo HY, Wang ZX, Wang DS, Pu HY, Zeng ZL, Li B, Xie D, Huang P, Hung MC, Chiao PJ, Xu RH (2019) Modulation of Redox Homeostasis by Inhibition of MTHFD2 in Colorectal Cancer: Mechanisms and Therapeutic Implications. J Natl Cancer Inst 111:584\u2013596. https:\/\/doi.org\/10.1093\/jnci\/djy160","journal-title":"J Natl Cancer Inst"},{"key":"6451_CR9","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1002\/2211-5463.13249","volume":"11","author":"Q Li","year":"2021","unstructured":"Li Q, Yang F, Shi X, Bian S, Shen F, Wu Y, Zhu C, Fu F, Wang J, Zhou J, Chen Y (2021) MTHFD2 promotes ovarian cancer growth and metastasis via activation of the STAT3 signaling pathway. FEBS Open Bio 11:2845\u20132857. https:\/\/doi.org\/10.1002\/2211-5463.13249","journal-title":"FEBS Open Bio"},{"key":"6451_CR10","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1159\/000495402","volume":"51","author":"H Lin","year":"2018","unstructured":"Lin H, Huang B, Wang H, Liu X, Hong Y, Qiu S, Zheng J (2018) MTHFD2 Overexpression Predicts Poor Prognosis in Renal Cell Carcinoma and is Associated with Cell Proliferation and Vimentin-Modulated Migration and Invasion. Cell Physiol Biochem 51:991\u20131000. https:\/\/doi.org\/10.1159\/000495402","journal-title":"Cell Physiol Biochem"},{"key":"6451_CR12","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.dld.2016.04.015","volume":"48","author":"X Liu","year":"2016","unstructured":"Liu X, Huang Y, Jiang C, Ou H, Guo B, Liao H, Li X, Yang D (2016) Methylenetetrahydrofolate dehydrogenase 2 overexpression is associated with tumor aggressiveness and poor prognosis in hepatocellular carcinoma. Dig Liver Dis 48:953\u2013960. https:\/\/doi.org\/10.1016\/j.dld.2016.04.015","journal-title":"Dig Liver Dis"},{"key":"6451_CR11","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12967-025-06267-y","volume":"23","author":"P Liu","year":"2025","unstructured":"Liu P, Huang F, Lin P, Liu J, Zhou P, Wang J, Sun H, Xing F, Ma H (2025) Histidine metabolism drives liver cancer progression via immune microenvironment modulation through metabolic reprogramming. J Transl Med 23:262. https:\/\/doi.org\/10.1186\/s12967-025-06267-y","journal-title":"J Transl Med"},{"key":"6451_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cca.2019.01.011","volume":"491","author":"SS Menon","year":"2019","unstructured":"Menon SS, Guruvayoorappan C, Sakthivel KM, Rasmi RR (2019) Ki-67 protein as a tumour proliferation marker. Clin Chim Acta 491:39\u201345. https:\/\/doi.org\/10.1016\/j.cca.2019.01.011","journal-title":"Clin Chim Acta"},{"key":"6451_CR14","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1038\/ncomms4128","volume":"5","author":"R Nilsson","year":"2014","unstructured":"Nilsson R, Jain M, Madhusudhan N, Sheppard NG, Strittmatter L, Kampf C, Huang J, Asplund A, Mootha VK (2014) Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer. Nat Commun 5:3128. https:\/\/doi.org\/10.1038\/ncomms4128","journal-title":"Nat Commun"},{"key":"6451_CR15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","volume":"34","author":"NN Pavlova","year":"2022","unstructured":"Pavlova NN, Zhu J, Thompson CB (2022) The hallmarks of cancer metabolism: Still emerging. Cell Metab 34:355\u2013377. https:\/\/doi.org\/10.1016\/j.cmet.2022.01.007","journal-title":"Cell Metab"},{"key":"6451_CR16","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1080\/15384047.2020.1824989","volume":"21","author":"RE Perez","year":"2020","unstructured":"Perez RE, Calhoun S, Shim D, Levenson VV, Duan L, Maki CG (2020) Prolyl endopeptidase inhibitor Y-29794 blocks the IRS1-AKT-mTORC1 pathway and inhibits survival and in vivo tumor growth of triple-negative breast cancer. Cancer Biol Ther 21:1033\u20131040. https:\/\/doi.org\/10.1080\/15384047.2020.1824989","journal-title":"Cancer Biol Ther"},{"key":"6451_CR17","doi-asserted-by":"publisher","first-page":"7244","DOI":"10.1021\/acs.jmedchem.7b00228","volume":"60","author":"Q Qi","year":"2017","unstructured":"Qi Q, Obianyo O, Du Y, Fu H, Li S, Ye K (2017) Blockade of Asparagine Endopeptidase Inhibits Cancer Metastasis. J Med Chem 60:7244\u20137255. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b00228","journal-title":"J Med Chem"},{"key":"6451_CR18","doi-asserted-by":"publisher","first-page":"6208","DOI":"10.1038\/s41598-021-85729-x","volume":"11","author":"S Routray","year":"2021","unstructured":"Routray S, Kumar R, Datta KK, Puttamallesh VN, Chatterjee A, Gowda H, Mohanty N, Dash R, Dixit A (2021) An integrated approach for identification of a panel of candidate genes arbitrated for invasion and metastasis in oral squamous cell carcinoma. Sci Rep 11:6208. https:\/\/doi.org\/10.1038\/s41598-021-85729-x","journal-title":"Sci Rep"},{"key":"6451_CR19","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1038\/s41467-021-22173-5","volume":"12","author":"M Shang","year":"2021","unstructured":"Shang M, Yang H, Yang R, Chen T, Fu Y, Li Y, Fang X, Zhang K, Zhang J, Li H, Cao X, Gu J, Xiao J, Zhang Q, Liu X, Yu Q, Wang T (2021) The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation. Nat Commun 12:1940. https:\/\/doi.org\/10.1038\/s41467-021-22173-5","journal-title":"Nat Commun"},{"key":"6451_CR21","doi-asserted-by":"publisher","first-page":"7013","DOI":"10.1111\/jcmm.16715","volume":"25","author":"Y Shi","year":"2021","unstructured":"Shi Y, Xu Y, Yao J, Yan C, Su H, Zhang X, Chen E, Ying K (2021) MTHFD2 promotes tumorigenesis and metastasis in lung adenocarcinoma by regulating AKT\/GSK-3\u03b2\/\u03b2-catenin signalling. J Cell Mol Med 25:7013\u20137027. https:\/\/doi.org\/10.1111\/jcmm.16715","journal-title":"J Cell Mol Med"},{"key":"6451_CR20","doi-asserted-by":"publisher","first-page":"1326509","DOI":"10.3389\/fimmu.2023.1326509","volume":"14","author":"X Shi","year":"2023","unstructured":"Shi X, Peng X, Chen Y, Shi Z, Yue C, Zuo L, Zhang L, Gao S (2023) Overexpression of MTHFD2 represents an inflamed tumor microenvironment and precisely predicts the molecular subtype and immunotherapy response of bladder cancer. Front Immunol 14:1326509. https:\/\/doi.org\/10.3389\/fimmu.2023.1326509","journal-title":"Front Immunol"},{"key":"6451_CR22","doi-asserted-by":"publisher","unstructured":"Wang W, Gu W, Tang H, Mai Z, Xiao H, Zhao J, Han J (2022) The Emerging Role of MTHFD Family Genes in Regulating the Tumor Immunity of Oral Squamous Cell Carcinoma. J Oncol 2022:4867730 https:\/\/doi.org\/10.1155\/2022\/4867730","DOI":"10.1155\/2022\/4867730"},{"key":"6451_CR23","doi-asserted-by":"publisher","first-page":"6361","DOI":"10.2147\/OTT.S210800","volume":"12","author":"Y Wei","year":"2019","unstructured":"Wei Y, Liu P, Li Q, Du J, Chen Y, Wang Y, Shi H, Wang Y, Zhang H, Xue W, Gao Y, Li D, Feng Y, Yan J, Han J, Zhang J (2019) The effect of MTHFD2 on the proliferation and migration of colorectal cancer cell lines. Onco Targets Ther 12:6361\u20136370. https:\/\/doi.org\/10.2147\/OTT.S210800","journal-title":"Onco Targets Ther"},{"key":"6451_CR24","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1111\/jcmm.14844","volume":"24","author":"C Yu","year":"2020","unstructured":"Yu C, Yang L, Cai M, Zhou F, Xiao S, Li Y, Wan T, Cheng D, Wang L, Zhao C, Huang X (2020) Down-regulation of MTHFD2 inhibits NSCLC progression by suppressing cycle-related genes. J Cell Mol Med 24:1568\u20131577. https:\/\/doi.org\/10.1111\/jcmm.14844","journal-title":"J Cell Mol Med"},{"key":"6451_CR25","doi-asserted-by":"publisher","first-page":"1098357","DOI":"10.3389\/fonc.2023.1098357","volume":"13","author":"H Zhang","year":"2023","unstructured":"Zhang H, Zhu S, Zhou H, Li R, Xia X, Xiong H (2023) Identification of MTHFD2 as a prognostic biomarker and ferroptosis regulator in triple-negative breast cancer. Front Oncol 13:1098357. https:\/\/doi.org\/10.3389\/fonc.2023.1098357","journal-title":"Front Oncol"},{"key":"6451_CR26","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1038\/s41388-021-01695-8","volume":"40","author":"LN Zhao","year":"2021","unstructured":"Zhao LN, Bj\u00f6rklund M, Caldez MJ, Zheng J, Kaldis P (2021) Therapeutic targeting of the mitochondrial one-carbon pathway: perspectives, pitfalls, and potential. Oncogene 40:2339\u20132354. https:\/\/doi.org\/10.1038\/s41388-021-01695-8","journal-title":"Oncogene"},{"key":"6451_CR27","doi-asserted-by":"publisher","first-page":"114412","DOI":"10.1016\/j.biopha.2023.114412","volume":"161","author":"F Zhou","year":"2023","unstructured":"Zhou F, Yuan Z, Gong Y, Li L, Wang Y, Wang X, Ma C, Yang L, Liu Z, Wang L, Zhao H, Zhao C, Huang X (2023) Pharmacological targeting of MTHFD2 suppresses NSCLC via the regulation of ILK signaling pathway. Biomed Pharmacother 161:114412. https:\/\/doi.org\/10.1016\/j.biopha.2023.114412","journal-title":"Biomed Pharmacother"},{"key":"6451_CR28","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.biopha.2023.114412","volume":"594","author":"W Zhu","year":"2016","unstructured":"Zhu W, Shao Y, Yang M, Jia M, Peng Y (2016) Asparaginyl endopeptidase promotes proliferation and invasiveness of prostate cancer cells via PI3K\/AKT signaling pathway. Gene 594:176\u2013182. https:\/\/doi.org\/10.1016\/j.biopha.2023.114412","journal-title":"Gene"}],"updated-by":[{"DOI":"10.1007\/s00432-026-06486-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000}}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-026-06451-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-026-06451-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-026-06451-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T15:31:25Z","timestamp":1778167885000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-026-06451-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,14]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["6451"],"URL":"https:\/\/doi.org\/10.1007\/s00432-026-06451-7","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,14]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In this article, the author's name Jiusong Han was incorrectly written as Jiusong Hang.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00432-026-06486-w","URL":"https:\/\/doi.org\/10.1007\/s00432-026-06486-w","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Stomatological Hospital, Southern Medical University (approval number AFSQ-0105). All animal experimental procedures complied with the ethical guidelines established by Sun Yat-sen University\u2019s animal care committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"67"}}